Rain Oncology (RAIN) Insider Trading & Ownership → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free RAIN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Rain Oncology (NASDAQ:RAIN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.40%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.18 MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$1.42 M Get RAIN Insider Trade Alerts Want to know when executives and insiders are buying or selling Rain Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RAIN Insider Buying and Selling by Quarter Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. Rain Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/18/2023Kevin C TangMajor ShareholderSell40,132$1.21$48,559.72 12/15/2023Kevin C TangMajor ShareholderSell109,435$1.20$131,322.00 10/13/2023Kevin C TangMajor ShareholderBuy131,631$0.99$130,314.69 10/11/2023Kevin C TangMajor ShareholderBuy74,812$0.97$72,567.64 6/1/2023Kevin C TangMajor ShareholderBuy333,325$1.11$369,990.75 5/30/2023Kevin C TangMajor ShareholderBuy588,768$1.03$606,431.04 5/22/2023Boxer Capital, LlcInsiderSell995,000$1.25$1,243,750.00 (Data available from 1/1/2013 forward) RAIN Insider Trading Activity - Frequently Asked Questions Who is on Rain Oncology's Insider Roster? The list of insiders at Rain Oncology includes Aaron I Davis, Boxer Capital, Llc, Bvf Partners L P/Il, Franklin M Berger, Kevin C Tang, and Perceptive Advisors Llc. Learn more on insiders at RAIN. What percentage of Rain Oncology stock is owned by insiders? 17.40% of Rain Oncology stock is owned by insiders. Learn more on RAIN's insider holdings. Which Rain Oncology insiders have been buying company stock? The following insiders have purchased RAIN shares in the last 24 months: Aaron I Davis ($5,667,995.96), Bvf Partners L P/Il ($9,971,387.14), Franklin M Berger ($351,000.00), and Kevin C Tang ($1,179,304.12). How much insider buying is happening at Rain Oncology? Insiders have purchased a total of 3,856,106 RAIN shares in the last 24 months for a total of $17,169,687.22 bought. Which Rain Oncology insiders have been selling company stock? The following insiders have sold RAIN shares in the last 24 months: Boxer Capital, Llc ($1,243,750.00), and Kevin C Tang ($179,881.72). How much insider selling is happening at Rain Oncology? Insiders have sold a total of 1,144,567 Rain Oncology shares in the last 24 months for a total of $1,423,631.72 sold. More Insider Trading Tools from MarketBeat Related Companies: LIAN Insider Ownership BIOR Insider Ownership PMVP Insider Ownership KNTE Insider Ownership NGM Insider Ownership DYAI Insider Ownership XAIR Insider Ownership BNGO Insider Ownership JUPW Insider Ownership CLNN Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NASDAQ:RAIN) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldElon to Transform U.S. Economy? Porter & CompanyUrgent Nvidia WarningAltimetryThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rain Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.